Safety and Immunogenicity of Inactivated and Recombinant Protein SARS-CoV-2 Vaccines in Patients With Thyroid Cancer

BACKGROUND: This study aimed at assessing the safety and immunogenicity of SARS-CoV-2 vaccines in patients with thyroid cancer. METHODS: This observational study included thyroid cancer patients between April 1, 2021, and November 31, 2021, in the Second Affiliated Hospital of Chongqing Medical Univ...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Yuling, Yang, Jiaxin, He, Danshuang, Feng, Yang, Liu, Xiaoman, Min, Yu, Fan, Shenghao, Yin, Guobing, Hu, Daixing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139473/
https://www.ncbi.nlm.nih.gov/pubmed/35634276
http://dx.doi.org/10.3389/fimmu.2022.855311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139473/
https://www.ncbi.nlm.nih.gov/pubmed/35634276
http://dx.doi.org/10.3389/fimmu.2022.855311

Ejemplares similares